Skip to content

Author

V. Borisevich

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A single-cycle, recombinant VSV platform Nipah vaccine cross-protects against Hendra virus in nonhuman primates

Nipah virus (NiV) and Hendra virus (HeV) are highly pathogenic paramyxoviruses that produce severe, often fatal disease in humans and animals. Zoonotic spillover of these henipaviruses from the Pteropid bat natural reservoir occurs near-annually in Southeast Asia and Oceania. Outbreaks of NiV disease frequently exceed...

Declan D. Pigeaud, V. Borisevich, Jacquelyn Turcinovic et al. · 0 citations
Open access Sep 2026

Self-adjuvanting Ebola virus-like particles that incorporate a cellular interferon-inducing domain

Ebola virus-like particle (EBOV VLP) vaccines composed of glycoprotein (GP), matrix protein VP40, and nucleoprotein (NP) typically require multiple adjuvanted doses to elicit protection. To enhance immunogenicity and mimic live virus infection, retinoic acid-inducible gene I (RIG-I) N-terminal CARD domains (2CARD), whi...

Naveen Thakur, Lin Wang, Tshidi Tsibane et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.